MBIO - Mustang Bio Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-481.1K

Cash

15.39M

Avg Qtr Burn

-15.35M

Short % of Float

0.51%

Insider Ownership

25.54%

Institutional Own.

9.30%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MB-107 Details X-Linked severe combined immunodeficiency	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-207 Details X-Linked severe combined immunodeficiency, Myelofibrosis	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-110 (LV-RAG1) Details Severe combined immunodeficiency due to complete RAG1/2 deficiency	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-106 (CD20) (Mustang Multicenter) Details Non-Hodgkin lymphoma, Cancer, Lymphoma, Chronic lymphocytic leukemia	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-106 (CD20) (Fred Hutch) Details Non-Hodgkin lymphoma, Lymphoma, Chronic lymphocytic leukemia, Multiple sclerosis, Epstein-Barr virus, Cancer, Waldenstrom macroglobulinemia	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-105 (PSCA) Details Prostate cancer, Multiple myeloma, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-104 Details Multiple myeloma, Solid tumor/s, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-103 (HER2) Details Glioblastoma, Metastatic breast cancer to brain, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-101 (IL-13Ra2) + MB-108 Details Glioblastoma, Ependymoma, Medulloblastoma, Leptomeningeal brain tumors	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MB-102 (CD123) Details High risk myelodysplastic syndromes , Blastic plasmacytoid dendritic cell neoplasm, Acute myeloid leukemia, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.